NEGRINI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 27.443
AS - Asia 12.127
EU - Europa 8.838
SA - Sud America 1.908
AF - Africa 194
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
Totale 50.544
Nazione #
US - Stati Uniti d'America 26.940
SG - Singapore 4.961
CN - Cina 3.634
DE - Germania 1.894
IT - Italia 1.704
BR - Brasile 1.596
UA - Ucraina 1.360
HK - Hong Kong 1.192
TR - Turchia 923
GB - Regno Unito 887
FI - Finlandia 722
PL - Polonia 602
VN - Vietnam 580
SE - Svezia 480
RU - Federazione Russa 383
CA - Canada 230
MX - Messico 229
ID - Indonesia 195
FR - Francia 176
IN - India 174
AR - Argentina 147
NL - Olanda 129
BE - Belgio 111
BD - Bangladesh 89
ZA - Sudafrica 85
ES - Italia 84
AT - Austria 75
JP - Giappone 74
CZ - Repubblica Ceca 67
EC - Ecuador 49
IQ - Iraq 48
LT - Lituania 46
RO - Romania 33
IR - Iran 31
PK - Pakistan 27
UZ - Uzbekistan 25
MA - Marocco 23
CO - Colombia 22
CL - Cile 21
AE - Emirati Arabi Uniti 20
VE - Venezuela 19
JO - Giordania 18
PY - Paraguay 18
IE - Irlanda 16
KR - Corea 16
AU - Australia 15
SA - Arabia Saudita 15
TN - Tunisia 15
CH - Svizzera 14
IL - Israele 14
UY - Uruguay 13
OM - Oman 12
DO - Repubblica Dominicana 11
DZ - Algeria 11
EG - Egitto 11
KE - Kenya 11
MY - Malesia 11
PE - Perù 10
BO - Bolivia 9
GR - Grecia 9
LB - Libano 9
EU - Europa 8
KZ - Kazakistan 8
NG - Nigeria 8
NP - Nepal 8
PH - Filippine 8
AL - Albania 6
AZ - Azerbaigian 6
LV - Lettonia 6
TW - Taiwan 6
CR - Costa Rica 5
DK - Danimarca 5
HN - Honduras 5
RS - Serbia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
CG - Congo 3
ET - Etiopia 3
GD - Grenada 3
HU - Ungheria 3
SR - Suriname 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
EE - Estonia 2
GH - Ghana 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LK - Sri Lanka 2
Totale 50.504
Città #
Fairfield 2.944
Woodbridge 2.756
Singapore 2.715
Ashburn 2.672
Houston 1.894
Chandler 1.547
Jacksonville 1.503
Beijing 1.234
Ann Arbor 1.188
Santa Clara 1.184
Hong Kong 1.179
Seattle 1.101
Wilmington 1.030
Cambridge 903
Munich 753
Warsaw 587
Izmir 561
New York 526
Los Angeles 467
Nanjing 467
Dallas 442
Ferrara 380
Princeton 346
San Diego 274
Boardman 250
Helsinki 244
Milan 237
Shanghai 209
Ho Chi Minh City 187
São Paulo 167
Mexico City 158
Turku 158
Jakarta 154
Nanchang 140
Shenyang 130
London 124
Tianjin 114
Hefei 113
Bremen 110
Brussels 104
Dearborn 103
Buffalo 98
Hanoi 97
Brooklyn 94
Addison 90
Chicago 90
Falls Church 87
Montreal 86
Denver 81
Dong Ket 81
Changsha 80
Hebei 71
The Dalles 69
Jiaxing 68
Moscow 67
Tokyo 67
Poplar 65
Bologna 64
Jinan 64
Johannesburg 63
Stockholm 63
Rome 62
Mountain View 61
Toronto 60
Atlanta 58
Falkenstein 57
Phoenix 57
Boston 56
San Mateo 56
Kunming 55
Rio de Janeiro 55
Chennai 53
Orem 52
Amsterdam 51
Nuremberg 50
San Francisco 50
Washington 50
Guangzhou 48
Redwood City 48
Brno 45
Norwalk 45
Manchester 44
Ningbo 43
Zhengzhou 43
Frankfurt am Main 42
Columbus 39
Vienna 39
Ankara 37
Auburn Hills 34
Hangzhou 33
Augusta 32
Philadelphia 32
Council Bluffs 30
Tappahannock 29
Verona 29
Mumbai 27
Belo Horizonte 26
Brasília 26
Orange 26
Des Moines 25
Totale 34.605
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 622
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 359
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 337
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 307
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 299
Absolute quantification of cell-free microRNAs in cancer patients 271
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 269
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 262
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 262
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 262
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 260
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 258
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 253
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 251
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 249
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 247
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 233
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 232
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 230
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 228
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 223
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 222
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 222
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 220
Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells 219
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 218
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 217
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 216
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 215
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 215
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 215
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 214
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 212
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 212
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 209
Circulating non-coding RNA as biomarkers in colorectal cancer 205
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 205
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 204
MicroRNA e cancro 204
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 203
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 202
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 202
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 202
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 201
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 196
BK virus, JC virus and simian virus 40 infection in humans, and association with human tumors 191
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 191
RASSF1A QUANTITATIVE METHYLATION-SPECIFIC DROPLET DIGITAL PCR IN URINARY CELLS AS BIOMARKER FOR PROSTATE CANCER DETECTION 191
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 191
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 191
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 190
Reprogramming of miRNA networks in cancer and leukemia 189
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 189
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 189
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 188
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 188
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 188
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 187
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 187
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 187
MicroRNA involvement in hepatocellular carcinoma 186
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 186
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 186
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 185
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 184
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo 183
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 183
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 183
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 182
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 182
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 181
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 181
A microRNA signature of hypoxia 180
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 178
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 177
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 177
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 177
Animal Models of Hepatocellular Carcinoma Prevention 175
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 174
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21 172
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer 172
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 171
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 171
Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor 169
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 169
Episomal DNA of a BK virus variant in a human insulinoma 168
Refined subchromosomal location of 21 expressed sequence tags from unknown genes at region 11p15 168
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 168
Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27 167
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 167
BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. In: POLYOMAVIRUSES AND HUMAN DISEASES 166
Non-coding RNAs in the reprogramming of glucose metabolism in cancer 166
Extensive modulation of a set of microRNAs in primary glioblastoma 165
MicroRNA response to environmental mutagens in liver 165
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 164
Aberrant FHIT transcripts in Merkel cell carcinoma 164
Cloning and characterization of two overlapping genes in a subregion at 6q21 involved in replicative senescence and schizophrenia 164
Analysis of MLH1 promoter methylation in colorectal carcinomas with microsatellite instability 164
Espressione dei MicroRNA nei carcinomi mammari 164
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 164
Totale 20.749
Categoria #
all - tutte 236.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.566
Totale 245.949


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.063 0 0 0 0 0 470 202 510 126 692 701 362
2021/20223.752 139 356 300 169 193 188 217 219 122 271 360 1.218
2022/20233.610 390 233 128 466 604 522 162 301 454 32 189 129
2023/20242.169 187 245 95 58 169 498 112 186 44 42 59 474
2024/20258.797 188 179 650 350 1.005 859 481 499 1.606 794 1.223 963
2025/202611.759 2.253 909 1.871 2.968 3.333 425 0 0 0 0 0 0
Totale 51.065